Slide 1: Second Quarter 2022 Earnings
Second Quarter 2022 Earnings July 27, 2022 1
Slide 2: Agenda
Agenda IDEX Business Overview Q2 2022 Financial Performance Segment Performance 2022 Guidance Summary Q&A IDEX Proprietary & Confidential 2
Slide 3: Replay Information
Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13724804 • Log on to: www.idexcorp.com IDEX Proprietary & Confidential 3
Slide 4: Cautionary Statement
Cautionary Statement Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other
Slide 5: Business Update
Business Update IDEX Proprietary & Confidential 5
Slide 6: IDEX Overview
IDEX Overview Strong Demand Continues • Record Sales and continued backlog build • Organic sales growth of 12% • Double-digit growth across all three segments Driving Operational Excellence • Managing supply chain environment • Lead times providing competitive advantage • Price-cost trending toward
Slide 7: Financials
Financials IDEX Proprietary & Confidential 7
Slide 8: IDEX Q2 2022 Financial Performance
IDEX Q2 2022 Financial Performance (Dollars in millions, excl. EPS) Sales Adjusted Earnings per Share* +12% Organic* 15% Increase $796 $2.02 $686 $1.75 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Adjusted Operating Margin* Free Cash Flow* 60 bps decrease 20% decrease 24.4% Q2 2022 includes incremental impact of
Slide 9: 2022 Adjusted Operating Income Walk
2022 Adjusted Operating Income Walk 2 (Dollars in millions) 8 22 $ 190 (4) 4 (9) $ 167 Q2'21 * Organic Price/ Mix Growth Discretionary Acq/FX Q2'22 * Adj Op Income Flow Thru Productivity/ Investments Adj Op Income Inflation Flow through Organic flow Total flow @ PY GM% through ex through 45% Acq / F
Slide 10: IDEX Segment Performance
IDEX Segment Performance Fluid & Metering Technology Health & Science Technology Fire & Safety / Diversified Q2 Revenue $300M / 38% of Total Q2 Revenue $326M / 41% of Total Q2 Revenue $171M / 21% of Total • Stable Industrial market • Strong secular growth trends • Dispensing project deliveries • Str
Slide 11: 2022 Guidance Summary
2022 Guidance Summary Third Quarter Full Year Current Prior Current Guidance Guidance Guidance Revenue% vs. Prior Year Organic* 9-10% 6-8% ~10% Operating Margin% Reported ~24% ~24% ~24% Earnings per Share Reported $1.80-$1.85 $6.87-$7.00 $7.19-$7.29 Adjusted* $1.98-$2.03 $7.50-$7.63 $7.88-$7.98 Othe
Slide 12: Appendix
Appendix IDEX Proprietary & Confidential 12
Slide 13: Fluid & Metering Technologies
Fluid & Metering Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* +8% Organic* +13% Organic* +170 bps* $319 28.4% $300 $278 $251 26.7% Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 Highlights: Steady Industrial demand Q2 Sales Mix: Organic 13% Strong Agriculture ma
Slide 14: Health & Science Technologies
Health & Science Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* +13% Organic* +12% Organic* -130 bps* 27.8% $343 $326 $283 $275 26.5% Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 Highlights: Q2 Sales Mix: Organic 12% Strong Life Sciences, Analytical Instrumentatio
Slide 15: Fire & Safety / Diversified Products
Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Adjusted Operating Margin* -5% Organic* +11% Organic* -280 bps* 26.7% $191 $171 $177 23.9% $161 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Q2 Sales Mix: Organic 11% Q2 Highlights: Orders driven by non-repeat of Dispensing
Slide 16: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of the Change in Net Sales to Organic Net Sales Three Months Ended June 30, 2022 FMT HST
Slide 17: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Reported-to-Adjusted Operating Income and Margin Three Months Ended June 30, 2022 202
Slide 18: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Reported-to-Adjusted Net Income Three Months Ended June 30, 2022 2021 Reported net in
Slide 19: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Three Months Ended June 30, Reconciliation of Reported-to-Adjusted EPS 2022 2021 Reported diluted EPS a
Slide 20: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Cash Flows from Operating Activities to Free Cash Flow Three Months Ended June 30, 20
Slide 21: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Estimated 2022 EPS to Adjusted EPS Attributable to IDEX Guidance Third Quarter 2022 F